DD271056A5 - Verfahren zur herstellung von festen arzneizubereitungen mit mikronisierten ebselen-kristallen - Google Patents

Verfahren zur herstellung von festen arzneizubereitungen mit mikronisierten ebselen-kristallen Download PDF

Info

Publication number
DD271056A5
DD271056A5 DD88316885A DD31688588A DD271056A5 DD 271056 A5 DD271056 A5 DD 271056A5 DD 88316885 A DD88316885 A DD 88316885A DD 31688588 A DD31688588 A DD 31688588A DD 271056 A5 DD271056 A5 DD 271056A5
Authority
DD
German Democratic Republic
Prior art keywords
ebselen
crystals
micronized
pharmaceutical preparations
ebseline
Prior art date
Application number
DD88316885A
Other languages
German (de)
English (en)
Inventor
Axel Roemer
Juergen Seidel
Original Assignee
�K@����������@���@���@����k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �K@����������@���@���@����k�� filed Critical �K@����������@���@���@����k��
Publication of DD271056A5 publication Critical patent/DD271056A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12—Selenazoles; Hydrogenated selenazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD88316885A 1987-06-20 1988-06-17 Verfahren zur herstellung von festen arzneizubereitungen mit mikronisierten ebselen-kristallen DD271056A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (1)

Publication Number Publication Date
DD271056A5 true DD271056A5 (de) 1989-08-23

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88316885A DD271056A5 (de) 1987-06-20 1988-06-17 Verfahren zur herstellung von festen arzneizubereitungen mit mikronisierten ebselen-kristallen

Country Status (25)

Country Link
US (1) US5021242A (es)
EP (1) EP0296389B1 (es)
JP (1) JPH0713016B2 (es)
KR (1) KR970005322B1 (es)
AT (1) ATE69165T1 (es)
AU (1) AU603454B2 (es)
CA (1) CA1310906C (es)
DD (1) DD271056A5 (es)
DE (2) DE3720493A1 (es)
DK (1) DK173628B1 (es)
ES (1) ES2041736T3 (es)
FI (1) FI88256C (es)
GE (1) GEP19960342B (es)
GR (1) GR3003084T3 (es)
HU (1) HU200096B (es)
IE (1) IE63512B1 (es)
LT (1) LT3669B (es)
LV (1) LV10381B (es)
MX (1) MX169170B (es)
NO (1) NO175133C (es)
NZ (1) NZ225066A (es)
PT (1) PT87767B (es)
RU (1) RU1834657C (es)
UA (1) UA12648A (es)
ZA (1) ZA884025B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
RU2143898C1 (ru) * 1993-10-27 2000-01-10 Дайити Фармасьютикал Ко., Лтд. Гранулированный фармацевтический препарат и водная суспензия на его основе
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
NZ501248A (en) * 1997-08-26 2001-06-29 Aventis Pharma Inc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080293777A1 (en) * 2007-05-23 2008-11-27 Erlanson Daniel A Weight Loss Treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
UA12648A (uk) 1997-02-28
KR970005322B1 (ko) 1997-04-15
AU603454B2 (en) 1990-11-15
DK333388A (da) 1988-12-21
GEP19960342B (en) 1996-02-20
NZ225066A (en) 1990-07-26
NO175133B (no) 1994-05-30
FI88256B (fi) 1993-01-15
JPH01100125A (ja) 1989-04-18
NO175133C (no) 1994-09-07
KR890000084A (ko) 1989-03-11
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
HUT50037A (en) 1989-12-28
ES2041736T3 (es) 1996-07-16
ATE69165T1 (de) 1991-11-15
IE63512B1 (en) 1995-05-03
PT87767B (pt) 1992-10-30
FI88256C (fi) 1993-04-26
CA1310906C (en) 1992-12-01
RU1834657C (ru) 1993-08-15
FI882912A (fi) 1988-12-21
DK333388D0 (da) 1988-06-17
IE881628L (en) 1988-12-20
ZA884025B (en) 1988-12-20
LT3669B (en) 1996-01-25
DE3866033D1 (de) 1991-12-12
JPH0713016B2 (ja) 1995-02-15
GR3003084T3 (en) 1993-02-17
PT87767A (pt) 1989-05-31
LTIP903A (en) 1995-03-27
NO882615L (no) 1988-12-21
HU200096B (en) 1990-04-28
NO882615D0 (no) 1988-06-14
LV10381B (en) 1995-06-20
DE3720493A1 (de) 1989-01-26
US5021242A (en) 1991-06-04
FI882912A0 (fi) 1988-06-17
LV10381A (lv) 1995-02-20
AU1811688A (en) 1988-12-22
MX169170B (es) 1993-06-23
DK173628B1 (da) 2001-05-07

Similar Documents

Publication Publication Date Title
DD271056A5 (de) Verfahren zur herstellung von festen arzneizubereitungen mit mikronisierten ebselen-kristallen
EP0550807A2 (de) Verwendung von Präparaten der Curcuma-Pflanzen
DD201974A5 (de) Verfahren zur herstellung von festen arzneizubereitungen enthaltend nifedipin
DE3027073A1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-on enthaltende pharmazeutische praeparate und ihre verwendung
DD259858A5 (de) Verfahren zur herstellung von kristallinem torasemid der modifikation i
EP0675717A1 (de) Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung
EP0796103A1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
DE3603564A1 (de) Pharmazeutische praeparate mit analgetrischer wirksamkeit, sowie deren herstellung und verwendung
DE2710327A1 (de) Carcinostatisches mittel
DE3019244C2 (es)
DE3638124C2 (de) Neue pharmazeutische Verwendung von Ebselen
EP0871437B1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE3027074A1 (de) Benzisoselenazolon enthaltende pharmazeutische praeparate und ihre verwendung
EP0665830B1 (de) Tilidin-dihydrogenorthophosphat, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
EP0147735B1 (de) Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE4024885A1 (de) Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
EP1524273B1 (de) Verfahren zur Herstellung von trans- oder cis-Diammoniumdichlorodihydroxoplatin (IV)-Salzen und -Derivaten und ihre Verwendung zur Herstellung von pharmazeutischen Wirkstoffen
EP0164587A2 (de) Nifedipinpräparate und Verfahren zu ihrer Herstellung
DE2126810A1 (de) Verfahren zur Herstellung von Tab letten
EP0268813B1 (de) Verfahren zur Herstellung eines bindemittelfreien tablettierfähigen Celiprololhydrochlorid-Granulates
EP0022213A1 (de) Benzothiazol-2(3H)-one-Derivate enthaltende Arzneimittel
EP0347927A2 (de) Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on (Ebselen) zur Herstellung von Arzneimitteln zur Behandlung von Malaria
WO1993024130A1 (de) (-)-metrifonat enthaltendes arzneimittel
EP0165450A2 (de) Nifedipinkombinationspräparate und Verfahren zu ihrer Herstellung
DE10138561A1 (de) Tumorhemmende Cerverbindungen

Legal Events

Date Code Title Description
RPV Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act)
IF04 In force in the year 2004

Expiry date: 20080618